CEO ofDr. Dan Gooding stopped by our offices to give us an update on the successful clinical trial of their lead asset, NXP001, and the company's entry into the world of cannabinoids.
For more news and updates on Nuformix:
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
SP Angel research note on commodities and miners, featuring: AfriTin Mining* (ATM LN) – First concentrate from Uis tin project and offtake agreement Atalaya Mining (ATYM LN) – Mechanical completion of expansion to 15mtpa at Proyecto Riotinto BlueRock Diamonds* (BRD LN) – BlueRock sells another diamond for more than US$50,000 Cora Gold* (CORA LN) – Drilling results from Sanankoro Mkango Resources* (MKA LN) – Songwe Hill and Thambani project updates Rambler Metals & Mining* (RMM LN) – H1 2019 results, operational update and US$5m convertible loan Tri-Star Resources* (TSTR LN) – Operational update
The National Institute of Allergy and Infectious Diseases, which like the NIH falls under the US Department of Health & Human Services, will provide Motif Bio with preclinical services to evaluate the drug as a treatment for listeria.
Sainsbury (J) is kicking-off the search for a new chief executive to replace Mike Coupe as it looks to move on from its failed attempt to merge with Asda, Persimmon is on track to make another £1 billion in profits this year despite being criticised for providing substandard homes